Study area | Dose | Day 8 | Day 14 | EC50 (μg/ml thiabendazole) | ||
---|---|---|---|---|---|---|
FECR (%) unpairedc | FECR (%) pairedc | FECR (%) unpairedc | FECR (%) pairedc | |||
Nyala | 5 mg/kga | 78 (54–88) | 77 (76–81) | 62 (11–81) | 35 (27–42) | 0.13 (0.05–0.34) |
Kass | 5 mg/kga | 76 (18–91) | 77 (73–79) | 70 (28–88) | 56 (52–61) | 0.15 (0.07–0.33) |
10 mg/kgb | n.a.d | 77 (75–80) | n.a.d | 82 (80–85) |  |